New England Securities’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
BIT
BFA
New England Securities's PFE Position: Q4 2014 in Review
New England Securities reduced its Pfizer (PFE) stake by 7.3% in Q4 2014, selling an estimated $56.9K and leaving 25,135 shares worth $743K. The position accounts for 0.26% of the portfolio, ranked #99.
New England Securities first reported a position in PFE in Q2 2013 and has held it in 7 quarters since. The position peaked at $761K in Q3 2014. 1,860 funds tracked by Wall St. Rank hold PFE as of Q4 2014.
- New England Securities held 25,135 shares of Pfizer worth $743K as of Q4 2014.
- New England Securities sold 1,985 Pfizer shares in Q4 2014, an estimated $56.9K.
- Pfizer made up 0.26% of New England Securities's portfolio in Q4 2014, its #99 holding.
- New England Securities first reported a position in Pfizer in Q2 2013 and has held it in 7 quarters since.
- New England Securities's Pfizer position peaked at $761K in Q3 2014.
- 1,860 funds tracked by Wall St. Rank held Pfizer as of Q4 2014.
Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.